Pharma Pulse 3/6/25: Regulatory Agencies Role in Battle Against Misinformation, Developing Winning Supplemental Benefits Packages & more

The Role Regulatory Agencies Should Play in the Battle Against Misinformation

In this Pharmaceutical Executive video interview, Jen Butler, Chief Commercial Officer for Pleio, explores what kind of role regulatory agencies should play in the battle against misinformation.

Developing Winning Supplemental Benefits Packages

Facing a variety of financial pressures, health plans need to take a measured approach to identify supplemental benefit strategies that facilitate their success.

AI Drug Firm Recursion Wants to Be Amazon Prime of Pharma

AI drug developer Recursion Pharmaceuticals Inc. is considering an Amazon Prime-style subscription model for selling its pipeline of medicines.

MedaSystems Secures Additional Seed Financing to Advance Its AI-Driven Workflow Platform for Expanded Access and Investigator-Initiated Studies

MedaSystems announced additional funding from existing investors, Debiopharm Innovation Fund, Nina Capital, and Young Sohn, a co-founder of Veeva Systems. This investment underscores confidence in MedaSystems’ ability to modernize pre-approval access pathways through its AI-driven workflow platform. By streamlining Expanded Access and IIS workflows, MedaSystems helps pharmaceutical companies and healthcare providers efficiently manage requests, improve patient access, and capture real-world data to support evidence generation and regulatory submissions.

@TuftsMCResearch on LinkedIn

#TuftsMedicine @TuftsCEVR @jchambers241 talks with @PharmaCommerce about how #biosimilars cut costs, expand patient access and shape the market. He breaks down challenges, solutions and what’s next in the space.

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs